分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Sequential sequencing reveals the architecture and complexity of genomic variants in patients with Alport syndrome

Di Hongling, You Zhen, Wang Ling, Sun QingRong, Zhang Jiahui, Lv Qi, Wang Pei, Lai Ze, Wang Gang, Zheng Chunxia, Gong Liang, Liu Zhihong

Journal:Nature Communications

IF:15.7

DOI:10.1038/s41467-026-70936-9

PMID:

Published:2026-03-23

research field:医学遗传学分子生物学人类遗传学肾脏病学基因组学

Abstract

Alport syndrome (AS) is a prevalent inherited kidney disorder mainly caused by mutations in COL4A3, COL4A4, and COL4A5 genes. To elucidate the genetic variants of AS, we implemented a sequential sequencing strategy within a Chinese cohort of 555 patients, comprising whole-exome sequencing (WES) for all participants, followed by whole-genome sequencing (WGS), RNA sequencing (RNA-seq), and nanopore long-read sequencing (NLR-seq) for selected individuals. We identify 431 distinct variants in 509 (91.7%) patients, with 42.2% being novel. Beyond WES, additional sequencing approaches resolve 23 patients with noncoding, copy number, or structural variants. Notably, noncoding variants account for 16.2% of detected variants and exhibit ethnic-specific mutagenesis patterns. More interestingly, NLR-seq uncovers two novel types of structural variants, namely large insertions in intronic regions and complex duplication-inversion variants. This study provides deeper insights into the genetic architecture of AS and proposes a research paradigm for improving the genetic diagnosis of inherited diseases. Alport syndrome has diverse genetic causes that are often hard to detect. Here, the authors use a layered sequencing strategy in a large Chinese cohort to uncover coding and noncoding variants, including novel structural types, refining the genetic diagnosis of inherited kidney disease.

本文使用的Yeasen产品

购物车
客服
转染试用